Natural Killer Cell-Based Immunotherapy in Acute Myeloid Leukemia: Lessons for the Future.
The article by Curti and colleagues highlights the potential of natural killer (NK) cell-based adoptive cellular immunotherapy in oncology, currently boosted by advances in the knowledge on NK cell biology and in theirex vivoGMP manipulation. Several issues deserve attention to fully achieve the translation of these advances to the clinic.